Moleculin Biotech Competitors and Similar CompaniesClear all

Moleculin Biotech's competitors and similar companies include Northwest Biotherapeutics, Onconova Therapeutics and AVEO Pharmaceuticals.

	Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.	Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.	Onconova Therapeutics Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer.	AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
Founding Date	Founding Date 2006	Founding Date 1998	Founding Date 1998	Founding Date 2001
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Houston, US HQ	Locations Bethesda, US HQ	Locations Newtown, US HQ Boston, US Newtown, US Pennington, US	Locations Boston, US HQ
Employees	Employees 176% decrease	Employees 1721% increase	Employees 1732% decrease	Employees 1912% increase
Valuation ($)	Valuation ($) 7.5 m	Valuation ($) 349.5 m	Valuation ($) 20.9 m	Valuation ($) 515.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1.4m (FY, 2025)	Revenue (est.) $2.8m (FY, 2024)	Revenue (est.) $42.3m (FY, 2021)
Net income	Net income ($33.6m) (FY, 2025)	Net income ($60.2m) (FY, 2025)	Net income $9.2m (FY, 2024)	Net income ($53.3m) (FY, 2021)
Funding
Total funding raised	Total funding raised $ 491k	Total funding raised $ 135.9m	Total funding raised $ 88m	Total funding raised $ 224m